Loading...

Price Table

* Prices are based on daily market changes.
DateOpenHighLowCloseVolumeDelivery %20-Day sma50-Day sma200-Day sma
Loading...
Day High Low Range
TimeLowestHighestVolume
Loading...
Past Performance & Moving Averages
Day’sLow high rangeSMAStock performanceNifty performance
Loading...
PIVOT POINTS
NAMES4S3S2S1PIVOT POINTSR1R2R3R4
CLASSIC---------
WOODIE‘S----
FIBONACCI--
CAMARILLA-
Loading...
Trend Analysis
Loading...
Key Data
Market capBook valuestock p/eDividend yieldroceroesales growth (3Y)face value (3Y)
Profile
ERIS It was incorporated as “Eris Lifescience Private Limited” as on January 25, 2007, as a private limited company under the Companies Act 1956, at Ahmedabad, along with a certificate of incorporation granted by the Registrar of Companies, Gujarat, Dadra, and Nagar Haveli. According to a resolution of the Shareholders dated February 5, 2007, the company name was changed to “Eris Lifesciences Private Limited” and a fresh certificate of incorporation was being issued by the Registrar of Companies, Gujarat, Dadra, and Nagar Haveli as on February 9, 2007. Further, according to a conversion of the company to a public limited company, and as approved by the Shareholders via a resolution dated January 31, 2017, the company name was changed to “Eris Lifesciences Limited,” and the RoC also issued a fresh certificate of incorporation as on February 2, 2017.

Some of the Milestones:

  • 2007:
  • The incorporation of the company took place.
  • It launched the “Eris” division focused on the cardiology and diabetes segment.
  • 2008: It launched “Nikkos” division focused on gastroenterology and orthopedics segment.
  • 2009: It launched the “Adura” division focused on the cardiology and diabetes segment.
  • 2011: It launched the “Montana” division focused on the gynecology and pediatrics segment.
  • 2012: It launched the “Inspira” division focused on the cardiology segment.
  • 2014:
  • It launched the “Victus” division focused on the anti-diabetes segment.
  • It also set up the Assam Facility by the Company.
  • 2015: It launched the “Eris 2” division focused on the pain management segment.
  • 2016:
  • It acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now, Aprica Pharmaceuticals Private Limited).
  • It acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited.
  • It acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited.
  • 2017: It acquired the trademarks ‘UNION’, ‘REUNION’ and ‘BON UNION.’

Some of the Achievements:

  • 2013:
  • Frost & Sullivan awarded it the ‘Competitive Strategy Leadership’ award.
  • It was awarded the ‘Emerging Companies Excellence’ award for scalability of the business model and managing operational efficiencies by Business Today and Yes Bank.

Trading and Investment Terminology